PMC:7105881 / 23821-24268 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"744","span":{"begin":101,"end":116},"obj":"Disease"},{"id":"745","span":{"begin":274,"end":289},"obj":"Disease"}],"attributes":[{"id":"A744","pred":"tao:has_database_id","subj":"744","obj":"MESH:D001102"},{"id":"A745","pred":"tao:has_database_id","subj":"745","obj":"MESH:D001102"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":", these vaccines may generate potent neutralizing antibodies with strong protective immunity against viral infection. S1 subunit, for example, is much shorter than the full-length S protein, but it is no less able to induce strong immune responses and/or protection against viral infection (Li et al., 2013; Adney et al., 2019). Thus, this fragment can be used as an alternative target for subunit vaccine development. Despite their ability to ind"}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T97","span":{"begin":182,"end":189},"obj":"Body_part"}],"attributes":[{"id":"A97","pred":"fma_id","subj":"T97","obj":"http://purl.org/sig/ont/fma/fma67257"}],"text":", these vaccines may generate potent neutralizing antibodies with strong protective immunity against viral infection. S1 subunit, for example, is much shorter than the full-length S protein, but it is no less able to induce strong immune responses and/or protection against viral infection (Li et al., 2013; Adney et al., 2019). Thus, this fragment can be used as an alternative target for subunit vaccine development. Despite their ability to ind"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T98","span":{"begin":101,"end":116},"obj":"Disease"},{"id":"T99","span":{"begin":107,"end":116},"obj":"Disease"},{"id":"T100","span":{"begin":274,"end":289},"obj":"Disease"},{"id":"T101","span":{"begin":280,"end":289},"obj":"Disease"}],"attributes":[{"id":"A98","pred":"mondo_id","subj":"T98","obj":"http://purl.obolibrary.org/obo/MONDO_0005108"},{"id":"A99","pred":"mondo_id","subj":"T99","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A100","pred":"mondo_id","subj":"T100","obj":"http://purl.obolibrary.org/obo/MONDO_0005108"},{"id":"A101","pred":"mondo_id","subj":"T101","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"}],"text":", these vaccines may generate potent neutralizing antibodies with strong protective immunity against viral infection. S1 subunit, for example, is much shorter than the full-length S protein, but it is no less able to induce strong immune responses and/or protection against viral infection (Li et al., 2013; Adney et al., 2019). Thus, this fragment can be used as an alternative target for subunit vaccine development. Despite their ability to ind"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T250","span":{"begin":118,"end":120},"obj":"http://purl.obolibrary.org/obo/CLO_0050050"},{"id":"T251","span":{"begin":291,"end":293},"obj":"http://purl.obolibrary.org/obo/CLO_0001022"},{"id":"T252","span":{"begin":291,"end":293},"obj":"http://purl.obolibrary.org/obo/CLO_0007314"}],"text":", these vaccines may generate potent neutralizing antibodies with strong protective immunity against viral infection. S1 subunit, for example, is much shorter than the full-length S protein, but it is no less able to induce strong immune responses and/or protection against viral infection (Li et al., 2013; Adney et al., 2019). Thus, this fragment can be used as an alternative target for subunit vaccine development. Despite their ability to ind"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T101","span":{"begin":182,"end":189},"obj":"Chemical"},{"id":"T102","span":{"begin":291,"end":293},"obj":"Chemical"}],"attributes":[{"id":"A101","pred":"chebi_id","subj":"T101","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"},{"id":"A102","pred":"chebi_id","subj":"T102","obj":"http://purl.obolibrary.org/obo/CHEBI_30145"}],"text":", these vaccines may generate potent neutralizing antibodies with strong protective immunity against viral infection. S1 subunit, for example, is much shorter than the full-length S protein, but it is no less able to induce strong immune responses and/or protection against viral infection (Li et al., 2013; Adney et al., 2019). Thus, this fragment can be used as an alternative target for subunit vaccine development. Despite their ability to ind"}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T35","span":{"begin":101,"end":116},"obj":"http://purl.obolibrary.org/obo/GO_0016032"},{"id":"T36","span":{"begin":231,"end":247},"obj":"http://purl.obolibrary.org/obo/GO_0006955"},{"id":"T37","span":{"begin":274,"end":289},"obj":"http://purl.obolibrary.org/obo/GO_0016032"}],"text":", these vaccines may generate potent neutralizing antibodies with strong protective immunity against viral infection. S1 subunit, for example, is much shorter than the full-length S protein, but it is no less able to induce strong immune responses and/or protection against viral infection (Li et al., 2013; Adney et al., 2019). Thus, this fragment can be used as an alternative target for subunit vaccine development. Despite their ability to ind"}

{"project":"2_test","denotations":[{"id":"32265848-23573979-36511102","span":{"begin":302,"end":306},"obj":"23573979"},{"id":"32265848-30832356-36511103","span":{"begin":322,"end":326},"obj":"30832356"}],"text":", these vaccines may generate potent neutralizing antibodies with strong protective immunity against viral infection. S1 subunit, for example, is much shorter than the full-length S protein, but it is no less able to induce strong immune responses and/or protection against viral infection (Li et al., 2013; Adney et al., 2019). Thus, this fragment can be used as an alternative target for subunit vaccine development. Despite their ability to ind"}

{"project":"LitCovid-sentences","denotations":[{"id":"T145","span":{"begin":118,"end":328},"obj":"Sentence"},{"id":"T146","span":{"begin":329,"end":418},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":", these vaccines may generate potent neutralizing antibodies with strong protective immunity against viral infection. S1 subunit, for example, is much shorter than the full-length S protein, but it is no less able to induce strong immune responses and/or protection against viral infection (Li et al., 2013; Adney et al., 2019). Thus, this fragment can be used as an alternative target for subunit vaccine development. Despite their ability to ind"}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T453","span":{"begin":50,"end":60},"obj":"GO:0042571"},{"id":"T454","span":{"begin":101,"end":106},"obj":"NCBITaxon:10239"},{"id":"T455","span":{"begin":180,"end":189},"obj":"PG_1"},{"id":"T456","span":{"begin":231,"end":237},"obj":"UBERON:0002405;GO:0006955"},{"id":"T457","span":{"begin":238,"end":247},"obj":"GO:0006955"},{"id":"T458","span":{"begin":274,"end":279},"obj":"NCBITaxon:10239"},{"id":"T84855","span":{"begin":50,"end":60},"obj":"GO:0042571"},{"id":"T99228","span":{"begin":101,"end":106},"obj":"NCBITaxon:10239"},{"id":"T19086","span":{"begin":180,"end":189},"obj":"PG_1"},{"id":"T31810","span":{"begin":231,"end":237},"obj":"UBERON:0002405;GO:0006955"},{"id":"T88093","span":{"begin":238,"end":247},"obj":"GO:0006955"},{"id":"T69429","span":{"begin":274,"end":279},"obj":"NCBITaxon:10239"}],"text":", these vaccines may generate potent neutralizing antibodies with strong protective immunity against viral infection. S1 subunit, for example, is much shorter than the full-length S protein, but it is no less able to induce strong immune responses and/or protection against viral infection (Li et al., 2013; Adney et al., 2019). Thus, this fragment can be used as an alternative target for subunit vaccine development. Despite their ability to ind"}